medline.ch Onkologie Blut

	KIT and FLT3-ITD mutations do not predict outcomes in pediatric core-binding factor acute myeloid leukemia: findings from the C-HUANAN-AML-15 multicenter cohort study. Ann Hematol Zheng Y, Yu L, Le S, Li N, Feng X, Li C, Zheng M, Mai H, Jiang H, He X, Wen H, Xu H, Chen C, Yang L. PMID: 42268406 [PubMed - as supplied by publisher]
	The context-dependent role of the dsRNA response in linking A-to-I editing and ADAR to normal hematopoiesis and leukemia. Front Cell Dev Biol Li X, Xu J, Yu J. PMID: 42267183 [PubMed]
	Establishment and validation of a 28-day clinical outcome prediction model for acute promyelocytic leukemia based on an early platelet-coagulation factor combined transfusion strategy. Am J Cancer Res Zheng S, Zheng X, Li Z. PMID: 42266758 [PubMed]
	A study comparing the efficacy of R-CHOP and R-DA-EPOCH regimens in young, high-risk treatment-naÃ¯ve diffuse large B-cell lymphoma patients: a multicenter retrospective analysis. Am J Cancer Res Lan H, Ding Y, Liu M. PMID: 42266738 [PubMed]
	Predicting isocitrate dehydrogenase mutation status in acute myeloid leukemia from gene expression profiles by machine learning. NAR Genom Bioinform Jung I, Vitte AL, Chuffart F, Chevalier S, Mossuz P, Khochbin S, Bourova-Flin E. PMID: 42266574 [PubMed - in process]
	Beyond Chemoimmunotherapy: Emerging Cellular and Targeted Therapies in Transformed Follicular Lymphoma: A Scoping Review. Cancer Control Al-Mashdali AF, Ghasoub R, Hwafdeh S, Yassin MA. PMID: 42265975 [PubMed - in process]
	CSF ctDNA Molecular Clearance as a Prognostic Biomarker for Orelabrutinib-Treated Primary Central Nervous System Lymphoma: Insights From Comparison With PET-CT. Am J Hematol Sheng L, Hu H, Lai Y, Wang S, Wang D, Tang S, Xu K, Sun Y, Zhang P, Lai B, Hu L, Chen L, Pan Y, Nie S, Gao X, Fan L, Ouyang G. PMID: 42265756 [PubMed - as supplied by publisher]
	Upregulation of NFS1 and downregulation of GSDMD as prognostic biomarkers in acute myeloid leukemia: implications for diagnosis and therapeutic strategies. BMC Cancer Radwan SM, Mostafa D, Radwan RA, Elghobary HA, Elghamry WR, Kamal AM. PMID: 42265630 [PubMed - in process]
	LncRNA IRAIN inhibits mantle cell lymphoma progression by inducing cell cycle arrest and apoptosis: an in vitro study. Sci Rep Lin P, Zhang Y, Lu L, Ma X, Huang Y. PMID: 42265322 [PubMed - as supplied by publisher]
	Deep learning based individualized cross-platform molecular subtype classification of B-lineage acute lymphoblastic leukemia. NPJ Precis Oncol Cui B, Sun H, Zhao S, Fan R, Rao J, Wu W, Zhong Y, Wang R, Wang Y, Shi Q, Guo Y, Lin J, Huang Y, Han Y, Liu H, Chen X, Shen S, Wang H, Liu Y. PMID: 42265190 [PubMed - as supplied by publisher]
	Condensates in fusion oncoprotein-driven leukemia: new biology and therapeutic opportunities. Trends Cancer Michmerhuizen NL, Kriwacki RW, Mullighan CG. PMID: 42265005 [PubMed - as supplied by publisher]
	Epstein-Barr Virus (EBV)-Positive Diffuse Large B-cell Lymphoma Masquerading As Lupus Pneumonitis in a Young Woman With Systemic Lupus Erythematosus: A Diagnostic Odyssey. Cureus Anya OO, Mosallaei S, Wysham N. PMID: 42261517 [PubMed]
	Atypical Cutaneous Manifestation Leading to the Diagnosis of Chronic Lymphocytic Leukemia. Cureus Memon M. PMID: 42261453 [PubMed]
	Obinutuzumab, lenalidomide, and venetoclax for the initial treatment of patients with advanced-stage follicular lymphoma: Results of the Phase Ib/II LEVERAGE study. Hemasphere Cheah CY, Blombery P, Johnston A, Wight J, Lewis KL, Bennett R, Xie J, Vlachos S, Hunter SM, Gonzales J, Binks S, Seymour JF. PMID: 42261375 [PubMed]
	Exosomes liquid biopsy in Lymphoma precision medicine: applications and challenges. Cancer Cell Int Liu J, Peng Y, Zhang Y, Xiang H, Lu Y, Chen S, Lin C, Jiang T, Tang X, Liu Y, Yang Z. PMID: 42260559 [PubMed - as supplied by publisher]
	Composite CLL/SLL and Lymphoplasmacytic Lymphoma with IgM Anti-MAG Neuropathy: Clinicopathologic and Molecular Characterization of a Diagnostically Challenging Case. Ann Clin Lab Sci Yang R, Ye MT, Medeiros CG, Ye F, You MJ. PMID: 42259539 [PubMed - in process]
	Longitudinal Changes in Body Weight and Body Mass Index in Patients with Chronic-Phase Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors: A Retrospective Observational Study. Oncology Alshurafa A, Abdulgayoom M, Ghasoub R, M Mohammed W, R Wafi J, Al Ali F, Yassin MA. PMID: 42258604 [PubMed - as supplied by publisher]
	Anti-CD123 monoclonal antibodies as therapeutic agents for acute myeloid leukemia: a systematic review. Expert Rev Hematol Vito VM, Boff VA, Demarchi IG, de Moraes ACR. PMID: 42257293 [PubMed - as supplied by publisher]
	Diagnostic Significance of Circulating EBV-miR-BHRF1-3 and EBV-miR-BART2-5p in Lymphoma A Case-Control Study. Pak J Med Sci Kara A, Kizilkaya M, Balkan E, Erdem F, Turkez H. PMID: 42257093 [PubMed]
	Primary Extramedullary Acute Promyelocytic Leukemia Presenting as Cauda Equina Syndrome: A Rare Case Report and Diagnostic Challenge. Clin Case Rep Ali A, Ringor M, Khalid A, Garcia D, Konchada R, Ratnasabapathy R, Chae Y, Melikyan A, Yaghmour G. PMID: 42256917 [PubMed]

Artikel 1 - 20 / 168153

Seite 1 von 8408

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung